Modified citrus pectin orchestrates hepatic redox homeostasis through an Alistipes dispar-nicotinamide-sirtuin 1 axis to mitigate metabolic dysfunction-associated steatotic liver disease.
MCP alleviates MASLD through an A. dispar-nicotinamide-SIRT1 axis that restores metabolic, inflammatory, and redox homeostasis and identifies a key microbial signature associated with MCP efficacy.